STELLA ROSE LTD

Company number 13860440 ·

Active

This analysis was written by an AI from the company's public filings. It may contain errors or omissions and is not financial or professional advice.

STELLA ROSE LTD - Analysis Report

Company Number: 13860440

Analysis Date: 2025-07-20 17:46 UTC

Financial Health Assessment for STELLA ROSE LTD as of 31 January 2024


1. Financial Health Score: D

Explanation:
The company shows critical signs of financial distress despite some positive indicators. The net liabilities and negative shareholders’ funds point to a balance sheet "illness," though improved current asset management and fixed asset growth offer some hope. However, the large long-term debt and persistent net liabilities weigh heavily on the overall health score.


2. Key Vital Signs

Metric Value (2024) Interpretation
Net Assets (Shareholders’ Funds) £(65,653) (negative) Indicates the company’s liabilities exceed assets — a key symptom of financial strain.
Current Assets £295,441 Reasonably healthy short-term asset base, mostly debtors.
Cash at Bank £8,032 Very low cash reserves, a symptom of potential liquidity stress.
Debtors £287,409 Large amount tied up in receivables, which may delay cash inflow.
Current Liabilities £40,195 Manageable short-term obligations.
Net Current Assets £255,246 Positive working capital indicates short-term liquidity is stable.
Fixed Assets £1,003,049 Significant investment in long-term assets (property/improvements) — “capital health.”
Long-term Creditors £1,323,948 Very high long-term debt, including substantial director loans — major concern for solvency.

3. Diagnosis: Financial Condition Summary

  • Balance Sheet Health: The company’s net liabilities (negative net assets) reveal an underlying "balance sheet illness." Despite owning significant fixed assets valued at over £1 million, the company’s total liabilities exceed its total assets, primarily driven by high long-term debt of £1.32 million. This indicates that the company is "over-leveraged," a common symptom of financial distress.

  • Liquidity and Cash Flow: The company shows a positive net current asset position (£255,246), suggesting a "healthy short-term liquidity" status. However, the very low cash balance (£8,032) combined with large debtors (£287,409) could indicate cash flow timing issues — the business might be waiting on payments to meet obligations, a symptom that requires careful monitoring.

  • Debt Structure: A major concern is the substantial increase in director loans (£1,050,000) recorded as long-term liabilities. While director loans can be flexible, the sheer size suggests dependency on internal financing and points to cash flow or funding "symptoms of distress."

  • Profitability & Reserves: The company has accumulated losses, reflected in the negative retained earnings (£65,753). This persistent deficit signals ongoing operating losses or insufficient profitability to build reserves — a "chronic symptom" that undermines financial stability.

  • Growth & Investment: The increase in fixed assets from £384,714 (2023) to £1,003,049 (2024) shows active investment in property and equipment, which is promising for future operational capacity but also increases capital commitments and debt risk.

  • Industry Context: Operating in real estate management and owning real estate assets fits the high fixed asset and debt profile but requires strong cash flow management given the capital intensity.


4. Recommendations: Path to Financial Wellness

  1. Improve Cash Flow Management:

    • Accelerate debtor collections to convert £287,409 receivables into cash. Consider stricter credit control or incentives for early payment.
    • Maintain a cash buffer to avoid liquidity shocks; explore short-term financing if necessary.
  2. Debt Restructuring:

    • Negotiate with lenders, including the director loan provider, to restructure or extend debt repayment terms. Spreading out repayments can alleviate immediate cash flow pressure.
    • Assess opportunities to reduce debt through asset sales if feasible without harming operational capacity.
  3. Profitability Enhancement:

    • Review operating costs and seek ways to increase revenue streams or fees from real estate management.
    • Explore whether all fixed asset investments are yielding appropriate returns; consider deferring non-critical capital expenditures.
  4. Regular Financial Monitoring:

    • Implement monthly financial health checks focusing on liquidity ratios and cash flow forecasts.
    • Engage with financial advisors or accountants for periodic reviews and scenario planning.
  5. Strengthen Equity Base:

    • If possible, seek additional equity injections to improve net asset position and reduce financial risk.
    • Alternatively, retain earnings from future profits to rebuild reserves.

Explanation in Layman's Terms (Medical Analogy):

STELLA ROSE LTD currently suffers from "balance sheet illness," where its debts outweigh its assets, similar to a patient carrying excess weight that strains the heart. While the company's "short-term pulse" (liquidity) is stable, its "cash flow heartbeat" is weak due to low cash and high amounts owed by customers. The large director loan is like a vital organ working overtime to keep the patient alive but cannot be relied on indefinitely. Without intervention to improve cash flow and reduce debt, the company risks worsening financial "health" that could lead to insolvency.


Perspective: Financial Health Diagnostician · Model: gpt-4.1-mini · Generated 20 July 2025

Sign in to generate a free AI analysis of this company — no password needed, just an email link.